BofA Securities Upgrades Galera Therapeutics (GRTX) to Neutral
Tweet
Share
E-mailGet Alerts GRTX Hot Sheet
Price: $0.15 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad upgraded Galera Therapeutics (NASDAQ: GRTX) from Underperform to Neutral with a price target of $4.00 (from $2.00).
For an analyst ratings summary and ratings history on Galera Therapeutics click here. For more ratings news on Galera Therapeutics click here.
Shares of Galera Therapeutics closed at $1.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
- Deutsche Bank Upgrades Target Hospitality (TH) to Buy
- Nomura/Instinet Upgrades Sunway Healthcare Holdings (SUNMED:MK) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
